XML 21 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
6 Months Ended
Oct. 26, 2013
Stock-Based Compensation [Abstract]  
Stock-based compensation expense recognized in consolidated statement of income
The table below summarizes the total stock-based compensation expense recognized for all outstanding grants in our consolidated statement of income:
 
 
 
Second Quarter Ended
  
Six Months Ended
 
 (Unaudited, amounts in thousands)
 
10/26/13
  
10/27/12
  
10/26/13
  
10/27/12
 
Equity-based awards expense
 
$
2,478
  
$
3,340
  
$
5,671
  
$
6,959
 
Liability-based awards expense
  
1,886
   
963
   
3,790
   
891
 
Total stock-based compensation expense
 
$
4,364
  
$
4,303
  
$
9,461
  
$
7,850
 
Schedule of grants made during the period
The table below summarizes the grants made during the first six months of fiscal 2014:
 
(Unaudited, shares/units in thousands)
 
Shares/units
granted
 
Liability/
Equity
award
Settlement
Stock options
  
175
 
Equity
Common shares
Stock appreciation rights (“SARs”)
  
142
 
Liability
Cash
Restricted stock units – employees
  
122
 
Liability
Cash
Restricted stock units – directors
  
34
 
Equity
Common shares
Performance-based units
  
35
 
Liability
Cash
Performance-based shares
  
191
 
Equity
Common shares
Stock Options [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Valuation Assumptions
The fair value of stock options granted during the first quarter of fiscal 2014 was calculated using the following assumptions:
 
(Unaudited)
 
7/27/13
 
Risk-free interest rate
  
0.84
%
Dividend rate
  
0.84
%
Expected life in years
  
5.0
 
Stock price volatility
  
81.3
%
Fair value per share
 
$
11.63
 
Stock Appreciation Rights (SARs) [Member] | 2014 Grant Remeasured [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Valuation Assumptions
The fair value of the SARs granted during the first quarter of fiscal 2014 was remeasured at October 26, 2013, using the following assumptions:
 
(Unaudited)
 
10/26/13
 
Risk-free interest rate
  
1.60
%
Dividend rate
  
0.70
%
Expected life in years
  
4.64
 
Stock price volatility
  
65.16
%
Fair value per share
 
$
13.01
 
Stock Appreciation Rights (SARs) [Member] | 2013 Grant Remeasured [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Valuation Assumptions
In fiscal 2013, we granted SARs as described in our Form 10-K for the fiscal year ended April 27, 2013.  The fair value of the SARs granted during fiscal 2013 was remeasured at October 26, 2013, using the following assumptions:
 
(Unaudited)
 
10/26/13
 
Risk-free interest rate
  
1.60
%
Dividend rate
  
0.70
%
Expected life in years
  
3.71
 
Stock price volatility
  
51.75
%
Fair value per share
 
$
13.59